Skip to main content
Cardioxyl Pharmaceuticals logo
  • Company
  • Technology
  • Product Pipeline
  • Clinical Trials
  • Investors
  • News & Events
  • Contacts

Board of Directors

Charles Sanders, M.D.
Read More


Gary L. Stiles, M.D.
Read More


James Barrett, Ph.D.
Read More


Jeff Clark
Read More


Robert Garland, M.D.
Read More


Christopher A. Kroeger, M.D.
President and Chief Executive Officer
Read More

Nitroxyl Technology

Cardioxyl has developed proprietary expertise in the biology, physiology and chemistry of nitroxyl donors

View More

Our Mission

Cardioxyl's mission is to realize the potential of nitroxyl technology through the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease.

  • History of Cardioxyl
  • Management Team
  • Board of Directors
    • Charles Sanders, M.D.
    • Gary L. Stiles, M.D.
    • James Barrett, Ph.D.
    • Jeff Clark
    • Robert Garland, M.D.
    • Christopher A. Kroeger, M.D.
  • Clinical Advisory Board
  • Scientific Advisory Board
  • Scientific Founders

Privacy Policy Terms of Use Contacts


Exchange East, Suite 212
1450 Raleigh Road,
Chapel Hill, NC 27517
Main: (919) 869-8585

©2012 Cardioxyl Pharmaceuticals, Inc. All rights reserved.